Ferrara A, Dos Santos C, Cimbro M
Chemotherapy, University of Pavia, Italy.
Chemotherapy. 1996 Jan-Feb;42(1):37-46. doi: 10.1159/000239420.
The ability of double and triple combinations of antimicrobials with different mechanisms of action, such as teicoplanin, meropenem, gentamicin and sparfloxacin, to achieve synergisms was investigated in vitro on some moderate-level gentamicin-resistant (MLGR: 8 < or = MIC < or = 256 mg/l) and high-level gentamicin-resistant (HLGR: MIC > 500 mg/l) enterococci. On MLGR strains, a constant synergistic effect was achieved by a combination of teicoplanin with gentamicin or with meropenem, while generally addition, sometimes close to synergism, was exhibited by gentamicin-meropenem, gentamicin-sparfloxacin and teicoplanin-sparfloxacin associations. Triple combinations of teicoplanin, meropenem and gentamicin, or teicoplanin, sparfloxacin and gentamicin, always showed a remarkable advantage in terms of synergism over double combinations. On HLGR enterococci, the only double association showing an additive effect, sometimes close to synergism, was teicoplanin plus meropenem, while the triple combination of teicoplanin with gentamicin and meropenem always showed a marked synergistic effect. An effect very close to synergism was also shown by the combination of teicoplanin with sparfloxacin and gentamicin.
研究了具有不同作用机制的抗菌药物(如替考拉宁、美罗培南、庆大霉素和司帕沙星)的双重和三重组合在体外对一些中度耐庆大霉素(MLGR:8≤MIC≤256mg/L)和高度耐庆大霉素(HLGR:MIC>500mg/L)肠球菌产生协同作用的能力。在MLGR菌株上,替考拉宁与庆大霉素或与美罗培南的组合可产生持续的协同作用,而庆大霉素-美罗培南、庆大霉素-司帕沙星和替考拉宁-司帕沙星组合通常表现为相加作用,有时接近协同作用。替考拉宁、美罗培南和庆大霉素的三重组合,或替考拉宁、司帕沙星和庆大霉素的三重组合,在协同作用方面总是比双重组合具有显著优势。在HLGR肠球菌上,唯一显示相加作用(有时接近协同作用)的双重组合是替考拉宁加美罗培南,而替考拉宁与庆大霉素和美罗培南的三重组合总是显示出明显的协同作用。替考拉宁与司帕沙星和庆大霉素的组合也显示出非常接近协同作用的效果。